Reports - Medical Device Outsourced Manufacturing Market
Medical Device Outsourced Manufacturing Market Growth and Trends | Insights & Forecast 2025-2035 by Device Type (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Orthopedic Devices, Ophthalmology Devices, Diabetes Care Devices, Dental Devices, Respiratory Care Devices, Surgical Devices, Genecology/ Urology Devices, Personal Care, Neurology Devices, Other Devices) by Service Type (Device Development & Manufacturing Services, Quality Management Services, Packaging & Assembly by Type, Other Services) by Class of Device (Class II Medical Devices, Class I Medical Devices, Class III Medical Devices) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
USD 39.65 Billion
USD 171.5 Billion
14.25%
North America
Asia Pacific
2024
2021 - 2023
2025 - 2035
By Device Type, By Service Type, By Class of Device, By Region
The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.
The global Medical Device Outsourced Manufacturing Market is valued at USD 39.65 Billion in 2024 and is projected to reach a value of USD 171.5 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 14.25% between 2025 and 2035.
According to a February 2022 report from the Centers for Disease Control and Prevention (CDC), 4.6% of people have ever been diagnosed with coronary heart disease. Additionally, according to statistics from the National Cancer Institute (NCI), in 2020, there will be 1,806,590 new instances of cancer identified in the country, and by 2030, there will be 2.2 million cancer survivors. Rising demand for medical equipment used in diagnosing and treating chronic diseases is being caused by the predicted rise in their burden. The demand for contract manufacturing services is therefore anticipated to increase. Diagnostic medical tools used in vitro on biological samples to ascertain a persons health state. In vitro diagnostics (IVDs) cover a wide range, from simple self-tests for pregnancy and blood glucose checks for diabetics to complex diagnoses carried out in clinical laboratories. The segment is growing because of the implementation of strategic initiatives by several market participants. For instance, Tecan purchased Paramit, a global contract manufacturing and development firm primarily focused on medical devices and instruments for the life sciences, in August 2021. Tecans position in life sciences and in-vitro diagnostics (IVD) solutions is anticipated to be further strengthened by purchasing Paramit.
The expanding medical device industry significantly influences the markets expansion. For instance, the WHO update from 2022 estimates that there are 2 million various types of medical devices, which are divided into more than 7000 generic device groupings. Additionally, Rosti Romania obtained a fresh medical device contract in June 2021 for its brand-new production plant. This demonstrates the expansion of the global market for medical devices, which is driving up demand for contract manufacturing services. Additionally, some businesses lack the internal resources necessary to produce medical equipment. Contract manufacturing is therefore chosen to produce such products, thereby fostering the expansion of the market.
Governments in numerous APAC nations are pressuring manufacturers to adopt Industry 4.0 to accelerate the creation of cutting-edge medical products. For instance, Thailands 4.0 growth model led to the establishment of an inventive center to boost medtech device development and production. To help small and medium-sized businesses (SMEs) create newer technologies, the Intellectual Property Innovation-driven Entrepreneurship Center (IP-IDE) maintains its own data pool and patent information. The Thai government hopes to inspire Thai medical device companies to develop and expand into both domestic and international markets with the IP-IDE center. The increased use of medical equipment in hospitals, diagnostic labs, pharma, biotech companies, and academic and research institutions is another effect of the APAC regions expanding healthcare spending. Governments in this region have also introduced new healthcare programs, including Healthy China 2030 in China and the Ayushman Bharat - National Health Protection Scheme (AB PMJAY) in India.
The global Medical Device Outsourced Manufacturing market can be categorized as Device Type, Service Type, Class of Device, and Region. Based on Device Type, the market can be categorized into IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Orthopedic Devices, Ophthalmology Devices, Diabetes Care Devices, Dental Devices, Respiratory Care Devices, Surgical Devices, Gynaecology/ Urology Devices, Personal Care, Neurology Devices, and Other Devices. Furthermore, based on the segment Service Type, the market can be split further into Device Development & Manufacturing Services, Quality Management Services, Packaging & Assembly by Type, and Other Services. Additionally, based on the Class of Device, the market can be categorized into Class I Medical Devices, Class II Medical Devices, and Class III Medical Devices. Likewise, based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
In 2022, IVD devices dominated the market. IVD devices play a crucial role in diagnosing diseases and are widely used in hospitals, clinics, and laboratories. The increasing prevalence of chronic diseases, growing demand for point-of-care testing, and advancements in healthcare infrastructure are driving the adoption of IVD devices. Outsourced manufacturing allows medical device companies to focus on research and development and reduce manufacturing costs. Therefore, IVD devices are expected to accommodate the maximum market share in the global Medical Device Outsourced Manufacturing market.
Between 2023 and 2030, the device development and manufacturing services category is anticipated to grow fastest. These services are essential for developing and producing medical devices, ensuring their quality and regulatory compliance. Additionally, device development and manufacturing services help companies reduce costs and improve efficiency by leveraging the expertise and resources of outsourcing partners. Thus, they are in high demand in the global medical device industry, leading to their dominant market share.
Class II medical devices, including products such as X-ray machines, insulin pumps, and MRI scanners, require a higher level of control and regulation than Class I devices, making outsourcing the manufacturing process more beneficial for companies. The global Medical Device Outsourced Manufacturing market is expected to grow significantly in the coming years, with Class II devices accounting for a major share. Factors such as cost-effectiveness, the expertise offered by outsourcing partners, and technological advancements are driving the demand for outsourced manufacturing of Class II medical devices on a global scale.
The presence of a well-developed healthcare infrastructure, technologically advanced manufacturing facilities, and many outsourcing companies in the region has fueled the demand for vegan protein powders in North America. Additionally, The United States is the major contributor to the market growth in North America, driven by factors such as high healthcare expenditure, favorable government policies, and a strong focus on research and development. Furthermore, the increasing demand for quality medical devices, cost-effectiveness, and the need for efficient manufacturing processes are also propelling the growth of the medical device outsourcing market in North America.
In 2022, the market in Asia-Pacific was growing rapidly. This can be attributed to factors such as the increasing demand for medical devices, favorable government policies, low production costs, and a skilled labor force. Countries like China, India, and Japan are key players in this region and are attracting major outsourcing contracts due to their advanced manufacturing capabilities. Additionally, advancements in technology and the growing need for personalized healthcare solutions are further driving the Medical Device Outsourced Manufacturing market growth in the Asia Pacific region.
The global Medical Device Outsourced Manufacturing market is highly competitive, with several key players focusing on strategies such as mergers and acquisitions, partnerships, and collaborations to strengthen their market position. Some prominent players in the market include SGS SA, Laboratory Corporation of America Holdings, Euro fins Scientific, Pace Analytical Services Inc., Intertek Group plc, WuXiAppTec, North American Science Associates, LLC, TÜV SÜD, and Sterigenics U.S., LLC (GTCR, LLC). These companies focus on expanding their manufacturing capabilities and geographical presence to gain a competitive edge in the market.
The key players in the global Medical Device Outsourced Manufacturing market include - SGS SA (Switzerland) among others.
| Parameter | Details |
|---|---|
| Segment Covered | By Device Type
By Service Type
By Class of Device
By Region
|
| Companies Covered |
|
| Customization Scope | Enjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data. |
| Pricing and purchase options | Access flexible purchase options tailored to your specific research requirements. Explore purchase options |
Key features include:
Contact
Toll Free Number+1 (877) 462-2282